KCM
TMO icon

KRS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

KRS Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Hold
1,191
– – 0.28% 62
2026
Q1 		$585K Hold
1,191
– – 0.36% 57
2025
Q4 		$690K Sell
1,191
-32
-3% -$18.1K 0.4% 54
2025
Q3 		$593K Sell
1,223
-64
-5% -$29.8K 0.36% 59
2025
Q2 		$522K Sell
1,287
-12
-0.9% -$5.02K 0.35% 65
2025
Q1 		$646K Sell
1,299
-18
-1% -$9.75K 0.51% 45
2024
Q4 		$685K Buy
1,317
+20
+2% +$11K 0.48% 46
2024
Q3 		$802K Sell
1,297
-83
-6% -$49.1K 0.58% 35
2024
Q2 		$763K Sell
1,380
-50
-3% -$28.6K 0.57% 35
2024
Q1 		$831K Buy
1,430
+83
+6% +$46.6K 0.67% 31
2023
Q4 		$715K Sell
1,347
-50
-4% -$24.2K 0.67% 41
2023
Q3 		$707K Hold
1,397
– – 0.75% 35
2023
Q2 		$729K Buy
1,397
+56
+4% +$30.2K 0.73% 33
2023
Q1 		$773K Buy
1,341
+5
+0.4% +$2.82K 0.87% 29
2022
Q4 		$736K Buy
1,336
+10
+0.8% +$5.3K 1.01% 27
2022
Q3 		$672K Hold
1,326
– – 0.93% 28
2022
Q2 		$720K Hold
1,326
– – 1.03% 26
2022
Q1 		$783K Hold
1,326
– – 0.85% 30
2021
Q4 		$884K Buy
+1,326
New +$828K 0.76% 27

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

KRS Capital Management's TMO Position: Q2 2026 in Review

KRS Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,191 shares worth $597K. The position accounts for 0.28% of the portfolio, ranked #62.

KRS Capital Management first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $884K in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • KRS Capital Management held 1,191 shares of Thermo Fisher Scientific worth $597K as of Q2 2026.
  • KRS Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.28% of KRS Capital Management's portfolio in Q2 2026, its #62 holding.
  • KRS Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • KRS Capital Management's Thermo Fisher Scientific position peaked at $884K in Q4 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.